颅骨成形术后早期并发症的多中心队列研究:德国颅骨重建登记处结果
该研究基于德国颅骨重建登记处前瞻性多中心数据库分析502例颅骨成形术患者,评估术后30天内早期手术相关并发症。结果显示45例(9.0%)需手术翻修,总体死亡率为0.8%(4例),术前mRS评分升高和ASA评分是手术翻修的独立预测因素,缺血性卒中作为基础诊断与较低翻修率相关。
要点
- 颅骨成形术后30天内手术翻修率为9.0%(45例),总体死亡率为0.8%(4例)。
- 术前mRS评分(OR 1.46,95%CI 1.08-1.97,p=0.014)和ASA评分(OR 2.89,95%CI 1.42-5.89,p=0.003)是手术翻修的独立预测因素。
- 缺血性卒中作为基础诊断与较低翻修率相关(OR 0.18,95%CI 0.06-0.57,p=0.004), compared with TBI。
核心结论
- 作者提供了关于颅骨成形术后手术相关并发症的II级证据数据,并识别了特定的术前风险因素,这些结果可能为优化这些患者的治疗提供额外指导。
研究设计与样本
- 前瞻性多中心数据库(德国颅骨重建登记处)分析502例颅骨成形术患者,评估术后30天内早期并发症、病史、死亡率和出院时改良Rankin量表(mRS)神经功能结局,主要终点为术后30天内死亡或手术翻修。
主要发现
- 创伤性脑损伤(TBI)和缺血性卒中是最常见的基础诊断;230例(45.8%)使用自体骨瓣,最常见的工程材料为钛(80例[15.9%])、聚醚醚酮(57例[11.4%])和聚甲基丙烯酸甲酯(57例[11.4%])。
- 45例(9.0%)需手术翻修,总体死亡率为0.8%(4例);死亡原因与缺血相关2例、弥漫性实质内出血1例、心脏并发症1例。
- 手术翻修最常见原因为硬膜外血肿(占所有翻修的40.0%)、新发脑积水(22.0%)和硬膜下血肿(13.3%)。
- 术前mRS评分升高(OR 1.46,95%CI 1.08-1.97,p=0.014)和ASA评分(OR 2.89,95%CI 1.42-5.89,p=0.003)是手术翻修的独立预测因素。
- 缺血性卒中作为基础诊断与较低翻修率相关(OR 0.18,95%CI 0.06-0.57,p=0.004), compared with TBI。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cranioplasty (CP) is a crucial procedure after decompressive craniectomy and has a significant impact on neurological improvement. Although CP is considered a standard neurosurgical procedure, inconsistent data on surgery-related complications after CP are available. To address this topic, the authors analyzed 502 patients in a prospective multicenter database (German Cranial Reconstruction Registry) with regard to early surgery-related complications. METHODS: Early complications within 30 days, medical history, mortality rates, and neurological outcome at discharge according to the modified Rankin Scale (mRS) were evaluated. The primary endpoint was death or surgical revision within the first 30 days after CP. Independent factors for the occurrence of complications with or without surgical revision were identified using a logistic regression model. RESULTS: Traumatic brain injury (TBI) and ischemic stroke were the most common underlying diagnoses that required CP. In 230 patients (45.8%), an autologous bone flap was utilized for CP; the most common engineered materials were titanium (80 patients [15.9%]), polyetheretherketone (57 [11.4%]), and polymethylmethacrylate (57 [11.4%]). Surgical revision was necessary in 45 patients (9.0%), and the overall mortality rate was 0.8% (4 patients). The cause of death was related to ischemia in 2 patients, diffuse intraparenchymal hemorrhage in 1 patient, and cardiac complications in 1 patient. The most frequent causes of surgical revision were epidural hematoma (40.0% of all revisions), new hydrocephalus (22.0%), and subdural hematoma (13.3%). Preoperatively increased mRS score (OR 1.46, 95% CI 1.08-1.97, p = 0.014) and American Society of Anesthesiologists Physical Status Classification System score (OR 2.89, 95% CI 1.42-5.89, p = 0.003) were independent predictors of surgical revision. Ischemic stroke, as the underlying diagnosis, was associated with a minor rate of revisions compared with TBI (OR 0.18, 95% CI 0.06-0.57, p = 0.004). CONCLUSIONS: The authors have presented class II evidence-based data on surgery-related complications after CP and have identified specific preexisting risk factors. These results may provide additional guidance for optimized treatment of these patients.
引用
- Sauvigny T, Giese H, Höhne J, et al. A multicenter cohort study of early complications after cranioplasty: results of the German Cranial Reconstruction Registry. J Neurosurg. 2021. PMID: 34920418. doi:10.3171/2021.9.JNS211549
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。